Abstract
Markers of β-cell maturity would be useful in staging the differentiation of stem/progenitor cells to β-cells whether in vivo or in vitro. We previously identified markers for newly formed β-cells in regenerating rat pancreases after 90% partial pancreatectomy. To test the generality of these markers of newly formed β-cells, we examined their expression during the perinatal period, a time of recognized β-cell immaturity. We show by semi-quantitative RT-PCR and immunostaining over the time course from embryonic day 18/20 to birth, 1 day, 2 days, 3 days, 7 days, and adult that MMP-2, CK-19, and SPD are truly markers of new and immature β-cells and that their expression transiently peaks in the perinatal period and is not entirely synchronous. The shared expression of these markers among fetal, newborn, and newly regenerated β-cells, but not adult, strongly supports their use as potential markers for new β-cells in the assessment of both the maturity of stem cell-derived insulin-producing cells and the presence of newly formed islets (neogenesis) in the adult pancreas. © 2010 Aye et al.
Author supplied keywords
Cite
CITATION STYLE
Aye, T., Toschi, E., Sharma, A., Sgroi, D., & Bonner-Weir, S. (2010). Identification of markers for newly formed β-cells in the perinatal period: A time of recognized β-cell immaturity. Journal of Histochemistry and Cytochemistry, 58(4), 369–376. https://doi.org/10.1369/jhc.2009.954909
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.